CN Patent

CN105764501A — 改善比生群治疗效益的组合物

Assigned to Modern Pharmaceutical Co · Expires 2016-07-13 · 10y expired

What this patent protects

本发明公开一种通过改善单药治疗效力或降低副作用的方式改善在先受限于次选治疗效能的治疗剂的治疗效力的方法及组合物。所述方法及组合物是特别适用于比生群或其衍生物、其类似物或其前药。

USPTO Abstract

本发明公开一种通过改善单药治疗效力或降低副作用的方式改善在先受限于次选治疗效能的治疗剂的治疗效力的方法及组合物。所述方法及组合物是特别适用于比生群或其衍生物、其类似物或其前药。

Drugs covered by this patent

Patent Metadata

Patent number: CN105764501A
Jurisdiction: CN
Classification: —
Expires: 2016-07-13
Drug substance claim: No
Drug product claim: No
Assignee: Modern Pharmaceutical Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.